Initial results of rapid antigen tests for COVID-19 very promising Two antigen tests for rapid diagnosis of COVID-19, which detect the presence of SARS-CoV-2 virus proteins within 15 minutes after testing, show very promising initial results.
Reports continue to rise The number of reports continues to rise in all regions and in all age groups. Last week, in the week of 30 September, 27,485 new people who tested positive for COVID-19 were reported by the Municipal Public Health Services (GGDs).
Screening for chronic Q-fever is only cost-effective for specific groups RIVM has investigated for which groups screening for chronic Q-fever might be cost-effective.
Pneumococcal disease in the elderly The Health Council of the Netherlands is preparing an advice on pneumococcal vaccination for the elderly on request of the Ministry of Health, Welfare and Sport.
Statement on health care spending Down syndrome Recently a tweet containing a video from a Dutch tv-show about Down syndrome caused a lot of turmoil on Twitter.
Temporary dermal fillers prove harmless RIVM has conducted a market surveillance study of 26 so-called non-permanent fillers. All 26 products proved to be harmless.
Slight increase of the number of tuberculosis patients in 2016 For the second consecutive year, the number of tuberculosis (TB) patients in the Netherlands increased.
Promising biobased alternatives to controversial polar aprotic solvents There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .